logo
logo
Sign in

Macular Degeneration Treatment Market Strategic Insights and key Business Influencing Factors | Major Players – IVERIC bio, Kubota Pharmaceutical Holdings Co., Ltd, Bayer AG,.

avatar
Market newstrends
Macular Degeneration Treatment Market Strategic Insights and key Business Influencing Factors | Major Players – IVERIC bio, Kubota Pharmaceutical Holdings Co., Ltd, Bayer AG,.

Macular Degeneration Treatment Market is also known as age-related macular degeneration (AMD) is a neurodegenerative ocular disorder that destroy the part of the eye called the macula which  provides sharp, central vision needed for seeing objects clearly. When macula degenerates, it causes loss of central vision. It occurs when the capillaries around the fovea widen (become dilated) and leak, results in fluid build-up which impairing reflection of light and causing progressive vision loss. It usually first affects people in their 50s and 60s. The first symptom usually is a night blindness as disease progress person develops tunnel vision and eventually leads to loss of central vision.

Global macular degeneration treatment market is expected to grow at a steady CAGR in the forecast period of 2019-2026. Growing incidence ocular surface injuries as it can contribute to the neurotrophic keratitis and development of advanced therapies and treatment are the key factors for market growth

 Get Sample Report at :

https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-macular-degeneration-treatment-market

Competitive Analysis: Global Macular Degeneration Treatment   Market

Few of the major competitors currently working in the global macular degeneration treatment market are Neurotech, Gilead Sciences, Inc., F. Hoffmann-La Roche Ltd, Adverum, Allergan, Regeneron Pharmaceuticals, Inc, STEMCELL Technologies Inc, IVERIC bio, Kubota Pharmaceutical Holdings Co., Ltd, Bayer AG, Novartis AG, Sanwa Kagaku Kenkyusho Co., Ltd, Opthea Limited, Santen Pharmaceutical Co., Ltd, PanOptica, Inc, Bausch health, Alcon, Resolvyx Pharmaceuticals, Inc, Phio Pharmaceuticals Corp and others

 Key Pointers Covered in the Global Macular Degeneration Treatment Market Trends and Forecast to 2026

  • Global   Macular Degeneration Treatment Market New Sales Volumes
  • Global   Macular Degeneration Treatment  Market Replacement Sales Volumes
  • Global   Macular Degeneration Treatment Market Installed Base
  • Global   Macular Degeneration Treatment Market By Brands
  • Global   Macular Degeneration Treatment Market Size
  • Global   Macular Degeneration Treatment  Market Procedure Volumes
  • Global   Macular Degeneration Treatment Market Product Price Analysis
  • Global   Macular Degeneration Treatment Market Healthcare Outcomes
  • Global   Macular Degeneration Treatment Market Cost of Care Analysis
  • Global   Macular Degeneration Treatment Market Regulatory Framework and Changes
  • Global   Macular Degeneration Treatment Market Prices and Reimbursement Analysis
  • Global   Macular Degeneration Treatment Market Shares in Different Regions
  • Recent Developments for Global   Macular Degeneration Treatment Market Competitors
  • Global   Macular Degeneration Treatment Market Upcoming Applications
  • Global   Macular Degeneration Treatment Market Innovators Study

Get Detailed TOC:

https://www.databridgemarketresearch.com/toc/?dbmr=global-macular-degeneration-treatment-market

Key Developments in the Market:

  • In September 2019, Adverum reported positive 24-week clinical data from the first cohort of patients treated with a one-time intravitreal (IVT) dose of ADVM-022, gene therapy in the OPTIC phase I clinical trial in wet age-related macular degeneration (wet AMD).The trial demonstrated sustained improvements in retinal anatomy. The clinical trial results indicating potentially significant clinical benefits for patients with wet age-related macular degeneration.
  • In February 2019, Neurotech received Fast Track designation from the FDA for NT-501 or Renexus, a encapsulated cell therapy for the treatment of macular telangiectasia type 2 (MacTel). The FDA Fast Track designation enables the company to accelerate the development process which helps patients to have access on the treatment as quickly as possible.

 Scope of the Macular Degeneration Treatment   Market

  • Global Macular Degeneration Treatment Market By Types (Wet Macular Degeneration, Dry Macular Degeneration), Treatment (Drugs, Surgery), Route of Administration (Oral, Injectable and Others), End- Users (Hospitals, Homecare, Specialty Clinics, Ophthalmic Clinic and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026
  • Global macular degeneration treatment market is expected to grow at a steady CAGR in the forecast period of 2019-2026. Growing incidence ocular surface injuries as it can contribute to the neurotrophic keratitis and development of advanced therapies and treatment are the key factors for market growth
  • Macular degeneration is also known as age-related macular degeneration (AMD) is a neurodegenerative ocular disorder that destroy the part of the eye called the macula which  provides sharp, central vision needed for seeing objects clearly. When macula degenerates, it causes loss of central vision. It occurs when the capillaries around the fovea widen (become dilated) and leak, results in fluid build-up which impairing reflection of light and causing progressive vision loss. It usually first affects people in their 50s and 60s. The first symptom usually is a night blindness as disease progress person develops tunnel vision and eventually leads to loss of central vision.

Speak to Author :

https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-macular-degeneration-treatment-market

Key insights in the report:

  • Complete and distinct analysis of the market drivers and restraints
  • Key Market players involved in this industry
  • Detailed analysis of the Market Segmentation
  • Competitive analysis of the key players involved

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

Browse Related Report Here:

CNS Stimulants Market

Biliary Atresia Treatment Market

collect
0
avatar
Market newstrends
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more